Resources » Monitoring Patient Safety in Clinical Trials
LINKS
DETAILS

Year: 2022

Language: English

This resource is also available in: French Russian Spanish

Author(s): World Federation of Hemophilia

Format: Document

Monitoring Patient Safety in Clinical Trials

ADDITIONAL INFORMATION

Ensuring patient safety is of paramount importance during the clinical trial process. There are many levels of study approval and monitoring to protect the safety of participants in clinical trials, and a system in place for collecting and reporting safety outcomes during a study.

The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

RELATED RESOURCES